Alzheimer's Type

3 registered clinical trials studyying Alzheimer's Type.

Status	Trial	Sponsor	Phase
Completed	Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previo NCT02192554	Otsuka Pharmaceutical Development & Commercialization, Inc.	—
Completed	Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation NCT01922258	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3
Completed	A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, NCT01862640	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3